News Image

NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025

Provided By GlobeNewswire

Last update: May 7, 2025

– Late Breaking BROADWAY and TANDEM data presented at EAS 2025 and simultaneously published in The New England Journal of Medicine (BROADWAY) and The Lancet (TANDEM) –

Read more at globenewswire.com

NEWAMSTERDAM PHARMA CO NV-27

NASDAQ:NAMSW (6/18/2025, 8:11:04 PM)

9.77

+0.95 (+10.77%)


NEWAMSTERDAM PHARMA CO NV

NASDAQ:NAMS (6/18/2025, 8:11:04 PM)

After market: 18.35 +0.15 (+0.82%)

18.2

-0.29 (-1.57%)



Find more stocks in the Stock Screener

Follow ChartMill for more